2025-524206-15-00招募中1 期
A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 120
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission HUB
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health2025-522920-28-00Novo Nordisk A/S100
招募中
1 期
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseNCT07411560Novo Nordisk A/S100
已完成
1 期
A research study to look at how CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weightObesity2023-504792-24-00Novo Nordisk A/S60
招募中
1 期
Investigating how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes.2023-509483-20-00Novo Nordisk A/S150
招募中
3 期
Weight loss in people living with overweight or obesity following treatment with cagrilintide2024-519530-24-00Novo Nordisk A/S120